Arendt assisted Alvotech with all Luxembourg law aspects of a business combination (de-SPACing) with Oaktree Acquisition Corp. II

Arendt assisted Alvotech with all Luxembourg law aspects of the agreement to enter into a business combination with Oaktree Acquisition Corp. II in order to create a leading publicly traded global biopharmaceutical company

10/12/2021

DEAL - SPAC - de-SPAC

SPAC is on the map 

Luxembourg, 10 December 2021

Arendt advised Alvotech Holdings S.A. (“Alvotech”), a fully integrated specialty biopharmaceutical group focused on the development and manufacturing of high quality biosimilar medicines, on all Luxembourg law aspects of the agreement to enter into a business combination (de-SPACing) with Oaktree Acquisition Corp. II, a SPAC sponsored by an affiliate of Oaktree Capital Management, L.P., and on all Luxembourg law aspects of structuring the business combination.

The combined group is expected to have an implied initial enterprise value of approximately USD 2.25 billion, and will enable further investment in the Alvotech platform and portfolio, furthering the company’s mission of bringing cost-effective biosimilars to patients in all major markets around the globe.

With unparalleled expertise in SPACs and de-SPACing transactions in Luxembourg, Arendt is optimally positioned to advise on the structuring, set-up, listing and subsequent business combination of SPACs in Luxembourg.

Arendt team involved:

YOU MIGHT ALSO WANT TO DISCOVER

06/06/2023
A new Governance for Arendt

Arendt appoints a new governance as of 1 April 2023 for a three-year term.

Read More_
06/06/2023

A new Governance for Arendt

Arendt appoints a new governance as of 1 April 2023 for a three-year term.
12/05/2023

Arendt & Medernach acted as Luxembourg counsel to Permira in connection with Permira VIII

Arendt & Medernach acted as Luxembourg counsel to Permira in connection with the formation of Permira VIII, its latest flagship global buyout fund, wh...
12/05/2023

Arendt & Medernach advises Cromwell European Real Estate Investment Trust in a EUR 70,630,...

Arendt has acted as borrower’s counsel in a sustainability-linked financing governed by Luxembourg law.
18/04/2023

Arendt & Medernach advised the DB1 Ventures in the EUR 8 million funding round of Next Gat...

Arendt assisted the Corporate Venture Capital unit of Deutsche Börse (“DB1 Ventures”) as lead investor in the Series A funding of Next Gate Tech